Stocks and Investing Stocks and Investing
Wed, December 6, 2023
Tue, December 5, 2023

Ed Arce Reiterated (TVTX) at Strong Buy and Held Target at $18 on, Dec 5th, 2023


Published on 2024-10-28 07:51:27 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Travere Therapeutics, Inc." (TVTX) at Strong Buy and Held Target at $18 on, Dec 5th, 2023.

Ed has made no other calls on TVTX in the last 4 months.



There are 8 other peers that have a rating on TVTX. Out of the 8 peers that are also analyzing TVTX, 3 agree with Ed's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $10 on, Wednesday, October 25th, 2023
  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023


These are the ratings of the 5 analyists that currently disagree with Ed


  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
Contributing Sources